This lawsuit is for anyone who acquired securities in Antares Pharma, Inc. (NASDAQ: ATRS) from December 21, 2016 though October 12, 2017.
The lawsuit alleges that the Company and certain of its executives violated federal law. Specifically, the lawsuit alleges that, throughout the time period mentioned above, the Company misled investors regarding its financial condition. More specifically, the lawsuit alleges that the Company led investors to believe that its product, Xyosted, would receive FDA approval despite knowing that the FDA would not approve the product because the Company had submitted to the FDA insufficient data for the FDA to consider approving the product.
On October 12, 2017, the Company disclosed that it received a letter from the FDA on October 11, 2017, which stated that the FDA had “identified deficiencies that preclude the continuation of the discussion of labeling and post marketing requirements/commitments” for Xyosted. On this news the price of the Company's stock dropped precipitously on unusually heavy trading volume. Then, on October 20, 2017, post-market, the Company announced that it received a Complete Response Letter from the FDA, “indicat[ing] that the FDA cannot approve the NDA in its present form” because “the FDA is concerned that XYOSTED could cause a clinically meaningful increase in blood pressure” and also because the product “raised a concern regarding the occurrence of depression and suicidality.” On this news the price of the Company's stock again dropped precipitously on unusually heavy trading volume.
The Law Offices of Howard G. Smith seeks to recover damages on behalf of class members. If you acquired securities in Antares Pharma, Inc. (NASDAQ: ATRS) from December 21, 2016 though October 12, 2017 you may join the lawsuit by submitting your information online, or you may call the Law Offices of Howard G. Smith and speak to Mr. Smith directly to learn how he can protect your rights.
Join the Class Action
First Name: *
Last Name: *
If Representing an Institution, Name of Institution:
If Representing an Institution, Position at Institution:
Mailing Address: *
Phone #: *
I, the Plaintiff, certify that:
1. I have reviewed the Complaint and authorized its filing.
2. Plaintiff did not purchase the security that is the subject of this
action, at the direction of plaintiff's counsel or in order to
participate in any private action arising under this title.
3. I am willing to serve as a representative party on behalf of a class
and will testify at deposition and trial, if necessary.
4. My transactions in the securities, which are the subject of this
action, during the Class Period set forth in the Complaint are as
5. I have not served as a representative party on behalf of a class
under the federal security laws during the last three years, except
if detailed below.
6. I will not accept any payment for serving as a representative party,
except to receive my pro rata share of any recovery or as ordered
or approved by the court including the award to a representative
plaintiff of reasonable costs and expenses (including lost wages)
directly relating to the representation of the class.
agreement and retain the Law Offices of Howard G. Smith and its associates to proceed on Plaintiff's behalf, on a contingent fee basis. If I am executing this agreement on behalf of an institution, I further certify that I am authorized to execute this agreement on behalf of the institution.